An easier way to manipulate malaria genes
New approach to knocking out parasite’s genes could make it easier to identify drug targets.
Kellis to lead MIT team in new phase of GTEx project to elucidate basis of disease predisposition
NIH-sponsored work to characterize genetic variation in human tissues with roles in diabetes, heart disease, and cancer.
Forced mutations doom HIV
New study reveals how a potential HIV drug exacts its toll on viral populations.
3 Questions: Kenneth Oye on the regulation of genetic engineering
Political scientist discusses regulatory gaps in assessing the impact of “gene drives.”
Bacteria: A day in the life
MIT study finds ocean bacteria follow predictable patterns of daily activity.
It’s in the genes — but whose?
Genetic material hitchhiking in our cells may shape physical traits more than we thought.
Ocean microbes display remarkable genetic diversity
One species, a few drops of seawater, hundreds of coexisting subpopulations.
Fast way to measure DNA repair
Test analyzing cells’ ability to fix different kinds of broken DNA could help doctors predict cancer risk.
Precision attack on cancer
Michael Hemann seeks better ways to deploy chemotherapy drugs and overcome tumor resistance.
Research reveals structure of key CRISPR complex
Work reveals how a genome-editing tool works to correct errors in the genetic code.
Unusual suspects
Computer models plus observations of RNA inside a cell help scientists home in on a short list of interesting RNA ‘machines.’
Biologists ID new cancer weakness
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.